Total Returns (Price + Dividend) 
Hemant Surgical for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Un-Audited Financial Results Of The Company For The Half Year Ended September 30 2026
14-Nov-2026 | Source : BSEUnaudited Financial Results (standalone and consolidated) of the Company for half year ended September 30 2026.
Board Meeting Outcome for Meeting Held On November 14 2026
14-Nov-2026 | Source : BSEUnaudited Financial Results (standalone and consolidated) of the Company for half year ended September 30 2026
Board Meeting Intimation for Considering And Approval Of Unaudited Financial Results Of The Company For The Half Year Ended September 30 2026
05-Nov-2026 | Source : BSEHemant Surgical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve Unaudited Financial Results Of The Company For The Half Year Ended September 30 2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Hanskumar Shamji Shah (24.26%)
Singularity Equity Fund I (6.19%)
23.24%
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 11.45% vs 17.99% in Mar 2025
Growth in half year ended Sep 2025 is 9.29% vs 55.66% in Mar 2025
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 0.87% vs -3.24% in Mar 2024
YoY Growth in year ended Mar 2025 is -17.04% vs 28.27% in Mar 2024